Our finding that lower BMI is associated with shorter survival in advanced HCC patients is consistent with studies showing that underweight is associated with larger tumors, poorer differentiation, macrovascular invasion, high AFP (>400 ng/ml), poor liver function, muscular dystrophy and tumor recurrence, all of which are predictors of poor prognosis in HCC [26–28]. Here, AFP is linked to neoplasm.